Zolmitriptan

CHEMBL1185 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

287.4 g/mol

LogP

2.2

Phase

4

This triptan medication is taken at the onset of a migraine headache to relieve pain, nausea, and sensitivity to light and sound. It works by stimulating serotonin receptors that cause the blood vessels in the brain to constrict and block pain signals. It is not for prevention of migraines and should not be used for hemiplegic or basilar migraines; people with cardiovascular disease should consult their doctor before use.

Moleküler Ağırlık

287,3600 g/mol

LogP

2,20

TPSA

57,40 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Cardiovascular Disease Parkinson's Disease Epilepsy Migraine Multiple Sclerosis Stroke

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12

InChI

InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1

Molecular Formula

C16H21N3O2

HBD / HBA

2 / 3

Döndürülebilir Bağlar

5

Ağır Atomlar

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This triptan medication is taken at the onset of a migraine headache to relieve pain, nausea, and sensitivity to light and sound. It works by stimulating serotonin receptors that cause the blood vessels in the brain to constrict and block pain signals. It is not for prevention of migraines and should not be used for hemiplegic or basilar migraines; people with cardiovascular disease should consult their doctor before use.

Yes, Zolmitriptan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1185. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 60857. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Zolmitriptan PillFYI'da

Yapı

Hızlı Veriler

Formül: C16H21N3O2
Eş Anlamlılar: 3

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.